Gemma Carvill is an Associate Professor in the Department of Neurology at Northwestern University. Her lab uses genomic technologies to define the molecular basis of epilepsy, including coding and non-coding variants. She integrates computational modeling with high-throughput assays of variant effect to understand which genetic variants cause epilepsy. Her work also leverages transcriptomics and epigenomics to understand disease mechanisms and identify and test novel gene-targeting therapeutics. At Northwestern, Dr. Carvill interfaces with the adult and pediatric clinical teams to expand neurogenetics research and to facilitate genetic diagnoses for patients and families. She is also committed to building epilepsy genomics infrastructure and accessibility to precision therapies in her home country, South Africa.